173 related articles for article (PubMed ID: 22815851)
1. Comparison of the predicted population coverage of tuberculosis vaccine candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a bioinformatics approach.
Davila J; McNamara LA; Yang Z
PLoS One; 2012; 7(7):e40882. PubMed ID: 22815851
[TBL] [Abstract][Full Text] [Related]
2. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy.
Dietrich J; Aagaard C; Leah R; Olsen AW; Stryhn A; Doherty TM; Andersen P
J Immunol; 2005 May; 174(10):6332-9. PubMed ID: 15879133
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the genetic diversity of Mycobacterium tuberculosis esxA, esxH, and fbpB genes among clinical isolates and its implication for the future immunization by new tuberculosis subunit vaccines Ag85B-ESAT-6 and Ag85B-TB10.4.
Davila J; Zhang L; Marrs CF; Durmaz R; Yang Z
J Biomed Biotechnol; 2010; 2010():208371. PubMed ID: 20617139
[TBL] [Abstract][Full Text] [Related]
4. Epitope promiscuity and population coverage of Mycobacterium tuberculosis protein antigens in current subunit vaccines under development.
Ong E; He Y; Yang Z
Infect Genet Evol; 2020 Jun; 80():104186. PubMed ID: 31923726
[TBL] [Abstract][Full Text] [Related]
5. Conservation in gene encoding Mycobacterium tuberculosis antigen Rv2660 and a high predicted population coverage of H56 multistage vaccine in South Africa.
Perez-Martinez AP; Ong E; Zhang L; Marrs CF; He Y; Yang Z
Infect Genet Evol; 2017 Nov; 55():244-250. PubMed ID: 28941991
[TBL] [Abstract][Full Text] [Related]
6. Performance of Homologous and Heterologous Prime-Boost Immunization Regimens of Recombinant Adenovirus and Modified Vaccinia Virus Ankara Expressing an Ag85B-TB10.4 Fusion Protein against
Kou Y; Wan M; Shi W; Liu J; Zhao Z; Xu Y; Wei W; Sun B; Gao F; Cai L; Jiang C
J Microbiol Biotechnol; 2018 Jun; 28(6):1022-1029. PubMed ID: 29847865
[TBL] [Abstract][Full Text] [Related]
7. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
8. Rational design of multiple TB antigens TB10.4 and TB10.4-Ag85B as subunit vaccine candidates against Mycobacterium tuberculosis.
Shi S; Yu L; Sun D; Liu J; Hickey AJ
Pharm Res; 2010 Feb; 27(2):224-34. PubMed ID: 19862606
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
[TBL] [Abstract][Full Text] [Related]
10. DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection.
Dalmia N; Klimstra WB; Mason C; Ramsay AJ
PLoS One; 2015; 10(8):e0136635. PubMed ID: 26317509
[TBL] [Abstract][Full Text] [Related]
11. Using epitope predictions to evaluate efficacy and population coverage of the Mtb72f vaccine for tuberculosis.
McNamara LA; He Y; Yang Z
BMC Immunol; 2010 Mar; 11():18. PubMed ID: 20353587
[TBL] [Abstract][Full Text] [Related]
12. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P
Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467
[TBL] [Abstract][Full Text] [Related]
13. Chimaeric protein improved immunogenicity compared with fusion protein of Ag85B and ESAT-6 antigens of Mycobacterium tuberculosis.
Xu Y; Wang B; Chen J; Wang Q; Zhu B; Shen H; Qie Y; Wang J; Wang H
Scand J Immunol; 2006 Nov; 64(5):476-81. PubMed ID: 17032239
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
Tang C; Yamada H; Shibata K; Maeda N; Yoshida S; Wajjwalku W; Ohara N; Yamada T; Kinoshita T; Yoshikai Y
J Infect Dis; 2008 May; 197(9):1263-74. PubMed ID: 18422438
[TBL] [Abstract][Full Text] [Related]
15. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6.
Langermans JA; Doherty TM; Vervenne RA; van der Laan T; Lyashchenko K; Greenwald R; Agger EM; Aagaard C; Weiler H; van Soolingen D; Dalemans W; Thomas AW; Andersen P
Vaccine; 2005 Apr; 23(21):2740-50. PubMed ID: 15780721
[TBL] [Abstract][Full Text] [Related]
16. Inactivated
Kuczkowska K; Copland A; Øverland L; Mathiesen G; Tran AC; Paul MJ; Eijsink VGH; Reljic R
Front Immunol; 2019; 10():1588. PubMed ID: 31354727
[TBL] [Abstract][Full Text] [Related]
17. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
[TBL] [Abstract][Full Text] [Related]
18. Immunological memory transferred with CD4 T cells specific for tuberculosis antigens Ag85B-TB10.4: persisting antigen enhances protection.
Duffy D; Dawoodji A; Agger EM; Andersen P; Westermann J; Bell EB
PLoS One; 2009 Dec; 4(12):e8272. PubMed ID: 20011592
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Ag85B vaccine by taking advantage of characteristics of human parainfluenza type 2 virus vector showed Mycobacteria-specific immune responses by intranasal immunization.
Watanabe K; Matsubara A; Kawano M; Mizuno S; Okamura T; Tsujimura Y; Inada H; Nosaka T; Matsuo K; Yasutomi Y
Vaccine; 2014 Mar; 32(15):1727-35. PubMed ID: 24486310
[TBL] [Abstract][Full Text] [Related]
20. Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis.
Billeskov R; Grandal MV; Poulsen C; Christensen JP; Winther N; Vingsbo-Lundberg C; Hoang TT; van Deurs B; Song YH; Aagaard C; Andersen P; Dietrich J
Eur J Immunol; 2010 May; 40(5):1342-54. PubMed ID: 20186878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]